includes:study
Are GLP1 side effects all the same?
Do some GLP1s have less negative side effects? They work the same, but can affect you differently -- let's look at the research.
GLP1.Guide Staff
Scouring sources for information on GLP1 Agonist drugs, so you don't have to.
category:news
23andMe gets into GLP1
23andMe leaves drug discovery, but embraces providing GLP1 Receptor Agonists -- emphasizing a shift to active preventative care.
includes:review
Systematic reviews of GLP1 worth reading
Want to get refreshed on GLP1 research into drugs like Ozempic, Wegovy, Mounjaro, Zepbound and others? Start here.
drug:amycretin
Novo's new GLP1: Amycretin
Novo has a new drug it's working on -- Amycretin. Amycretin is a dual agonist, with the *new* agonist being Amylin. Read more about it here.
category:news
GLP1's effect on ADHD
What effects does GLP1 have on ADHD? It's early, but we take a look at some published research.
categeory:watercooler
Life before GLP1s: Topiramate
Wondering what the world was doing before GLP1s? We discuss Topiramate, a popular appetite suppressant.
category:news
A new GLP1: Retatrutide
Is mimicking more hormones better? Let's find out -- the new GLP1 drug Retatrutide is a *triple* receptor agonist
category:news
Are GLP1s primarily brain drugs?
Are GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, etc) primarily brain drugs?
company:eli-lilly
Eli Lilly China approval and new suppliers
As the race to manufacture more GLP1 medications intensifies, Eli Lilly gets approval in China and more suppliers.
chemical:semaglutide
24% Less kidney disease risk with Semaglutide (Ozempic)
Can we trust research funded by Novo Nordisk which found a 24% decrease in kidney disease risk for people on Semaglutide (Ozempic)?
categeory:watercooler
How much are people actually paying for GLP1s?
We dive deep into the reports of people's GLP1 costs -- how much is the average person paying for Ozempic, Wegovy, Mounjaro, Zepbound and others?
drug:danuglipron
Pfizer's GLP1: Danuglipron
Read more about Dangulipron, Pfizer's GLP1 receptor agonist. Will it be better than Ozempic, Wegovy, Mounjaro, Zepbound and others?
Teneligliptin is for T2D, not weight loss
The name isn't easy to read (or say), but the results stand out – Teneligliptin is a drug used for type 2 diabetes that does not seem to correlate well to weight loss in general, unlike GLP1 agonists. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic,
drug:ozempic
Semaglutide (Ozempic) vs Tirzepatide (Mounjaro)
Learn the major differences between Ozempic (Semaglutide) and Mounjaro (Tirzepatide)
Reduced weight and heart benefits for women on Ozempic
A recent study showed that women can lose
categeory:watercooler
What people get wrong about Ozempic
We debunk some common misconceptions about GLP1 drugs like Ozempic, Wegovy, Mounjaro and others.